The Multidirectional Biological Activity of Resveratrol: Molecular Mechanisms, Systemic Effects and Therapeutic Potential—A Review
Nutrients · 2026
DOI: 10.3390/nu18020313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Łukasz Kogut und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioenergetics, Food Analysis and Microbiology, Institute of Food Technology and Nutrition, Faculty of Technology and Life Science, Univ…. Hauptthemen laut MEDLINE: Resveratrol, Antioxidants. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Resveratrol is a multi-target polyphenolic stilbene widely studied for its antioxidant, anti-inflammatory, cardioprotective, hepatoprotective, neuroprotective, immunomodulatory and anticancer properties. This review summarizes current evidence on its molecular mechanisms, therapeutic potential, metabolic interactions and biological implications, with particular emphasis on bioavailability, signaling pathways and organ-specific actions.
Methods
A comprehensive literature review was conducted focusing on recent in vitro, in vivo and clinical studies evaluating resveratrol’s biochemical activity, molecular targets and physiological effects. Special attention was given to oxidative stress regulation, inflammatory signaling, mitochondrial function, metabolic pathways, gut microbiota interactions, and its influence on chronic diseases.
Results
Resveratrol modulates several key signaling pathways including NF-κB, SIRT1, AMPK, MAPK, Nrf2 and PI3K/AKT/mTOR. It reduces oxidative stress, inhibits inflammatory cytokines, regulates apoptosis, improves mitochondrial performance, and activates endogenous antioxidant systems. The compound demonstrates protective effects in cardiovascular diseases, hepatic steatosis, neurodegenerative disorders, metabolic dysfunction, and various cancers through anti-inflammatory, anti-proliferative and anti-fibrotic mechanisms. Additionally, resveratrol beneficially alters gut microbiota composition and microbial metabolites, contributing to improved metabolic homeostasis. Despite high intestinal absorption, systemic bioavailability remains low; however, novel nanoformulations significantly enhance its stability and plasma concentrations.
Conclusions
Resveratrol exhibits broad therapeutic potential driven by its capacity to regulate oxidative, inflammatory, metabolic and apoptotic pathways at multiple levels. Its pleiotropic activity makes it a promising candidate for prevention and complementary treatment of chronic diseases. Advances in delivery systems and microbiota-derived metabolites may further enhance its clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioenergetics, Food Analysis and Microbiology, Institute of Food Technology and Nutrition, Faculty of Technology and Life Science, University of Rzeszów, Aleja Rejtana 16C, 35-959 Rzeszów, Poland.
- Department of Zoology, Institute of Zoology and Earth Sciences, University of the National Education Commission in Krakow, 30-084 Krakow, Poland.
ORCID-Profile: Grzegorz Zaguła
Zitieren
APA
Kogut, Ł., Puchalski, C., Katryńska, D., & Zaguła, G. (2026). The Multidirectional Biological Activity of Resveratrol: Molecular Mechanisms, Systemic Effects and Therapeutic Potential—A Review. Nutrients. https://doi.org/10.3390/nu18020313
Vancouver
Kogut Ł, Puchalski C, Katryńska D, Zaguła G. The Multidirectional Biological Activity of Resveratrol: Molecular Mechanisms, Systemic Effects and Therapeutic Potential—A Review. Nutrients. 2026. doi:10.3390/nu18020313
BibTeX
@article{Kogut2026,
author = {Kogut, Łukasz and Puchalski, Czesław and Katryńska, Danuta and Zaguła, Grzegorz},
title = {The Multidirectional Biological Activity of Resveratrol: Molecular Mechanisms, Systemic Effects and Therapeutic Potential—A Review},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18020313}
}
EUVIMED